Amgen (AMGN) Net Income (2009 - 2026)
Amgen (AMGN) recorded Net Income of $3.86 billion in Q3 2026, up 20.1% from $3.22 billion a year earlier and up 62.7% from the prior quarter.
Amgen (AMGN) Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Amgen's Net Income came in at $9.39 billion as of Sep 30, 2026, up 34.1% year-over-year; for FY2025, it came in at $7.71 billion, up 88.5% from FY2024.
- Annual Net Income has a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- Across earlier years, Net Income came in at $4.09 billion in FY2024 (-39.1%), $6.72 billion in FY2023 (+2.5%), $6.55 billion in FY2022 (+11.2%) and $5.89 billion in FY2021 (-18.9%).
- The Q3 2026 figure is the highest quarterly Net Income in data going back to Q1 2009.
- On a year-over-year basis, Net Income has increased for six consecutive quarters, with growth averaging 41.6% over the last seven quarters.
- Peak year-over-year performance for Net Income in the last five years was growth of 183.8% in Q2 2022, against a decline of 52.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.38 billion (Q2 2026), $1.82 billion (Q1 2026) and $1.33 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.95 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 6.45 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 210.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 4.22 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.07 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 3.25 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.86 Bn |
| Jun 30, 2026 | 2.38 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 3.22 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 627.00 Mn |
| Sep 30, 2024 | 2.83 Bn |
| Jun 30, 2024 | 746.00 Mn |
| Mar 31, 2024 | -113.00 Mn |
| Dec 31, 2023 | 767.00 Mn |
| Sep 30, 2023 | 1.73 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 2.84 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 2.14 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.90 Bn |
Amgen Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();